Neuropathic pain is a complex and often debilitating condition that affects millions of people worldwide. For those struggling to manage this type of pain, medications like Pregabalin and Gabapentin are frequently prescribed to provide relief. Pregabalin (Lyrica) and gabapentin (Neurontin) are medications that treat certain types of seizures and nerve pain. Pregabalin has more FDA approved uses. Both are frequently used off-label for a wide range of health conditions. When comparing pregabalin versus gabapentin, they work in similar ways but pregabalin is absorbed more quickly and fully. In the United Kingdom (UK), gabapentin and pregabalin are approved for the treatment of peripheral (both) and central (pregabalin only) neuropathic pain in adults [3, 4]. Gabapentinoids, a collective term for these drugs, have a similar structure and mechanism of action. Neuropathic pain after spinal cord injury (SCI) has a significant negative impact on the patients’ quality of life. The objective of this systematic review is to examine the safety and efficacy of pregabalin (PGB) and gabapentin (GBP) in the Pregabalin and gabapentin can be effective as first line treatment for some people with neuropathic pain such as post-herpetic neuralgia and diabetic peripheral neuropathy They are not effective for low back pain, sciatica, spinal stenosis, or episodic migraine, and their off-label use for these Neuropathic pain is a prevalent and burdensome condition, and both pregabalin and gabapentin are widely used for its treatment. However, there is a lack of clarity regarding their comparative efficacy and safety. This meta-analysis aims to evaluate Pregabalin is approved for additional uses, including fibromyalgia and nerve pain in certain adults. Healthcare providers commonly prescribe these medications for off-label uses (non-FDA-approved uses) as well, such as anxiety disorders. This randomized clinical trial assesses the effect of gabapentin vs pregabalin in leg pain intensity and compares adverse events among adults with chronic sciatica. Learn the similarities and differences of pregabalin vs gabapentin in treating neuropathic pain and seizures. Get informed for better treatment decisions. Use of gabapentin for central neuropathic pain is therefore off-label. However, gabapentin is recommended by NICE as a first-line treatment option for adults with all types of neuropathic pain (except trigeminal neuralgia). Interactions There are no clinically relevant pharmacokinetic interactions between gabapentin and pregabalin. Compared with gabapentin, pregabalin was more efficacious and safer for the treatment of neuropathic pain, with significant reductions in pain intensity and duration, opioid use, and adverse events. Conclusion: In conclusion, pregabalin demonstrated superior and faster efficacy in alleviating neuropathic pain than gabapentin did. Additionally, it improved patient-reported outcomes, resulted in lower opioid consumption, and led to fewer adverse events. Abstract Gabapentin and pregabalin are often considered first line treatment options for various neuropathic pain conditions. The purpose of this retrospective cohort study was to compare clinically meaningful pain reduction and other relevant outcomes among patients prescribed either gabapentin or pregabalin at the University of Arkansas for Medical Sciences (UAMS) Palliative Care Clinic (PCC Lyrica may also be used to treat neuropathic (nerve) pain associated with diabetic peripheral neuropathy or postherpetic neuralgia, spinal cord injury, and fibromyalgia Gabapentin may also be used to treat nerve pain caused by shingles (herpes zoster) and gabapentin enacarbil, brand name Horizant, is also approved for restless legs syndrome (RLS). Introduction: Neuropathic pain is a prevalent and burdensome condition, and both pregabalin and gabapentin are widely used for its treatment. However, there is a lack of clarity regarding their comparative efficacy and safety. This meta-analysis aims to evaluate and compare the effectiveness and Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety Neuropathic pain largely influences the well-being of patients. Anticonvulsant and antidepressant medications, such as Pregabalin, Gabapentin, and Amitriptyline, are routinely prescribed as initial treatments for neuropathic pain. The study sample I now advocate for deprescribing gabapentin when patients do not achieve adequate pain relief for chronic neuropathic pain at a cumulative daily dose of 1800 mg. Instead, I consider pregabalin as a substitute for gabapentin in patients with inadequate pain control rather than further dose escalations. Compared with gabapentin, pregabalin was more efficacious and safer for the treatment of neuropathic pain, with significant reductions in pain intensity and duration, opioid use, and adverse events. A randomized, blinded, fixed dose study that compared the efficacy of gabapentin and pregabalin in a population of 100 patients with neuropathic pain. There were significant reductions in visual analog scale (VAS) scores, a subjective measurement for acute and chronic pain, for both the gabapentin and pregabalin groups at 0-4 weeks, 0-8 weeks
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |